CoStar Group Inc. (C1GP34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 1.710 |
|---|---|
| 52-week range | 1.360 – 4.300 |
| Return, 1 month / 3 months | +19.6% / +12.5% |
| Return, 1 year / 3 years | −60.0% / −50.1% |
| Trend | Below its 200-day average |
| RSI (14) | 59 |
| Volatility (1 year) | 68.8% |
| Worst drawdown (1 year) | -67.9% |
| Average daily value traded | 0.03M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CoStar Group is a provider of real estate information, analytics and online marketplaces. It gathers and organises data on commercial properties, including offices, retail space, industrial buildings and land, and offers subscriptions to that research for brokers, owners, lenders and investors. The company also runs online marketplaces that connect renters and home seekers with apartments and homes for sale. CoStar Group is based in Washington, District of Columbia, and serves customers in the United States and other markets.
CoStar Group Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code C1GP34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CoStar Group Inc. (C1GP34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 1.710 on 27 October 2026.
Its price-based Market X-Ray is 22 out of 100 (a weak price profile), ranking 1,309 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 60.0% and over the last three months it rose 12.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 10 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.0% | ||
| From 52-week high | -60.2% | ||
| Momentum | 32 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 12.5% | ||
| 6-month return | -6.6% | ||
| 12-month return, skipping the last month | -66.5% | ||
| Stability (higher is calmer) | 11 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 68.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -67.9% | ||
| Liquidity | 46 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M BRL | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | +19.6% |
| 3 months | +12.5% |
| 6 months | −6.6% |
| 1 year | −60.0% |
| 3 years | −50.1% |
| 5 years | −65.8% |
Signals
| 50-day / 200-day average | 1.572 / 1.942 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.073 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.